The U.S. cardiovascular devices market is projected to nearly double from $22.08 billion in 2025 to $41.29 billion by 2032, driven by aging demographics and AI-powered clinical tools. Remote cardiac monitoring and minimally invasive surgery markets are expanding rapidly at 11.3% and 16.05% CAGRs respectively. Major industry players announced significant developments: GE HealthCare and Medtronic integrated surgical visualization systems, Intuitive Surgical received FDA clearance for da Vinci 5 cardiac procedures, and Johnson & Johnson presented mixed results from cardiac intervention trials.

The global ambulatory surgical equipment market is valued at USD 7.39 billion in 2026 and is expected to reach USD 14.58 billion by 2035, growing at a 7.85% CAGR. North America dominates with 34% market share, while Asia Pacific is the fastest-growing region. Endoscopy and laparoscopy systems lead by product type at 18% share, with compact intraoperative imaging expected to grow fastest. Independent ambulatory surgical centers account for 42% of the market.

The IoT in healthcare market is projected to grow from USD 207.4 billion in 2026 to USD 483.72 billion by 2031, with a CAGR of 18.46%. Growth is driven by remote patient monitoring adoption, connected medical devices, digital health advancements, and declining sensor costs. North America leads the market while Asia-Pacific emerges as the fastest-growing region.

The Global Biomedical Sensor Market is projected to grow from USD 10.79 Billion in 2024 to USD 20.95 Billion by 2032, at a CAGR of 15.87%. Growth is driven by increasing adoption of wearable health devices, rising prevalence of chronic diseases, and technological advancements in sensor miniaturization. However, stringent regulatory frameworks, high development costs, and data privacy concerns remain key challenges. North America dominates the market, while Asia-Pacific emerges as the fastest-growing region.

Five companies—VentriPoint Diagnostics, HeartBeam, Heartflow, Hyperfine, and GE Healthcare Technologies—are advancing AI-enabled cardiac diagnostic platforms to address the global heart disease crisis. Recent developments include VentriPoint's partnership with First Light Health for remote Indigenous communities, HeartBeam's collaboration with Mount Sinai on AI-ECG algorithms, Heartflow's new clinical registry data, Hyperfine's breakthrough stroke detection results, and GE Healthcare's role in the EU's COMPASS cardiotoxicity initiative.

Major M&A activity includes Public Storage's $10.5B acquisition of National Storage Affiliates, Mastercard's $1.8B purchase of stablecoin startup BVNK, and IBM's $11B acquisition of Confluent. Meanwhile, several companies filed for bankruptcy including Domino's franchisee, The Lycra Company, Baker & Taylor, and others, while some companies like GSI Technology and Perma-Pipe concluded strategic reviews without pursuing deals.

The global Respiratory Disease Testing Market is projected to grow from USD 5.99 billion in 2025 to USD 9.32 billion by 2032, with a CAGR of 6.50%. Growth is driven by advances in molecular diagnostics, digital imaging, telemedicine, and strategic partnerships. However, 2025 tariff revisions have impacted supply chains, prompting organizations to adopt flexible sourcing strategies and invest in local production capabilities.

Hospital networks are increasingly adopting AI-enhanced cardiac imaging technologies to reduce costs and improve patient outcomes. The AI medical imaging market is projected to reach nearly $20 billion by 2033, with echocardiography expected to grow to $2.64 billion by 2030. Key players including VentriPoint Diagnostics, Butterfly Network, Tempus AI, RadNet, and GE HealthCare are expanding their deployments across healthcare systems, with several reporting strong revenue growth and positive financial metrics.

RadNet (NASDAQ: RDNT) reported record Q4 revenue of $547.7M (up 14.8% YoY) and adjusted EBITDA of $87.7M (up 16.9% YoY), beating analyst estimates. The company announced a $270M acquisition of Paris-based AI radiology firm Gleamer to strengthen its Digital Health division. RadNet guided for 2026 imaging center revenue growth of 17-19% and digital health revenue growth of 46-56%. Shares rose 7.45% in premarket trading.

The global cardiology EHR market is valued at USD 3.52 billion in 2026 and is expected to reach USD 5.44 billion by 2035, growing at a 4.95% CAGR. North America leads the market while Asia Pacific shows the fastest growth. Web/cloud-based EHR systems dominate the product segment, with ambulatory surgery centers expected to grow fastest by end-use category.

The global tele-monitoring services market is valued at USD 36.59 billion in 2026 and is expected to reach USD 164.55 billion by 2035, growing at an 18.18% CAGR. North America leads the market while Asia Pacific shows the fastest growth. Remote patient monitoring dominates by service type, with wearables and mobile devices driving device segment growth. Key drivers include rising chronic disease prevalence, aging populations, and technological advancements in IoT and AI.

The global clinical analytics market is experiencing rapid expansion driven by widespread EHR adoption, AI/ML advancements, and real-world evidence acceptance. The market is projected to grow at a 19.7% CAGR from $33.09 billion in 2025 to $81.32 billion by 2030, with Asia-Pacific leading regional growth. Key drivers include digital health adoption, value-based care transition, and precision medicine demand.